Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1585, 2007-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Spironolactone "safer first-line" therapy for hypertension
Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. :
Prevalence and prognosis of resistant hypertension
Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. :
Device-based Therapies for Resistant Hypertension
Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. :
New drug targets for resistant hypertension look promising
Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. :